Cargando…

A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

BACKGROUND: A phase 1b study of photosensitizer TLD-1433–mediated photodynamic therapy (PDT) was performed in bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC) patients. OBJECTIVE: The primary objectives were safety and tolerability of PDT, with secondary objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Girish S., Lilge, Lothar, Nesbitt, Michael, Dumoulin-White, Roger J., Mandel, Arkady, Jewett, Michael A.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Bladder Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257636/ https://www.ncbi.nlm.nih.gov/pubmed/35813250 http://dx.doi.org/10.1016/j.euros.2022.04.015

Ejemplares similares

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
por: Collacott, Hannah, et al.
Publicado: (2023)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
por: Rezaee, Michael E., et al.
Publicado: (2021)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial
por: van Straten, Christine G.J.I., et al.
Publicado: (2023)

Treatment and disease management patterns for bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer in North America, Europe and Asia: A real-world data analysis
por: Broughton, Edward I., et al.
Publicado: (2022)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
por: Miyazaki, Masashi, et al.
Publicado: (2016)

How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020)

Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
por: Yu, Ge, et al.
Publicado: (2023)

Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
por: Ghafouri, Sayed Ab. Reshad, et al.
Publicado: (2018)

Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy
por: Rezvani, Sean, et al.
Publicado: (2019)

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy
por: Kaburaki, Kyohei, et al.
Publicado: (2017)

Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
por: Wang, Bin, et al.
Publicado: (2019)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy
por: Oh, Chee Won, et al.
Publicado: (2012)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
por: Samannodi, Mohammed, et al.
Publicado: (2018)

Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy
por: Nagai, Takashi, et al.
Publicado: (2019)

A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
por: Low, Li Sian, et al.
Publicado: (2021)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
por: Garcia, Cindy, et al.
Publicado: (2015)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer
por: Gupta, Sachin, et al.
Publicado: (2021)

Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: Case report
por: Alsulami, Hajar Aown Allah, et al.
Publicado: (2023)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017)

Combination of Intravesical Chemotherapy and Bacillus Calmette–Guerin Versus Bacillus Calmette–Guerin Monotherapy in Intermediate- and High-risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis
por: Cui, Jianfeng, et al.
Publicado: (2016)

Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
por: Saban, Marcia R, et al.
Publicado: (2008)

Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer
por: von Deimling, Markus, et al.
Publicado: (2023)

Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer
por: Veeratterapillay, Rajan, et al.
Publicado: (2021)

Mycobacterial Infection after Intravesical Bacillus Calmette-Guërin Treatment for Bladder Cancer: A Case Report
por: Park, Chang-Hun, et al.
Publicado: (2011)

Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guérin Instillation?
por: Hong, Sungwoo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iqbfn09kc9sdr997c09dgg31ge